MedAlerts Home
  Read the MedAlerts Blog Subscribe to the MedAlerts Blog 

Found 965 cases where Vaccine is VARZOS and Serious

Case Details

This is page 12 out of 97

Result pages: prev   3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21   next


VAERS ID:296419 (history)  Vaccinated:2007-10-10
Age:60.0  Onset:2007-10-26, Days after vaccination: 16
Gender:Female  Submitted:2007-11-09, Days after onset: 14
Location:North Carolina  Entered:2007-11-12, Days after submission: 3
Life Threatening? Yes
Died? No
Permanent Disability? Yes
Recovered? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: None
Current Illness: Stomach virus; Allergic reaction to antibiotics; Drug hypersensitivity
Preexisting Conditions:
Diagnostic Lab Data: Unknown 11/19/07-records received-Nerve conduction testing revealed moderately severe predominately motor demylinating polyneuropathy. MRI brain showing moderately prominent areas of white matter hyperintensity with intrepretation favoring
CDC 'Split Type': WAES0711USA01443
Vaccination
Manufacturer
Lot
Dose
Route
Site
VARZOS: ZOSTER (ZOSTAVAX)MERCK & CO. INC.  UNUN
Administered by: Other     Purchased by: Other
Symptoms: Demyelinating polyneuropathy, Guillain-Barre syndrome, Headache, Lumbar puncture, Muscular weakness, Nerve conduction studies abnormal, Nuclear magnetic resonance imaging brain abnormal, Pyrexia
SMQs:, Rhabdomyolysis/myopathy (broad), Peripheral neuropathy (narrow), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Guillain-Barre syndrome (narrow), Noninfectious encephalopathy/delirium (broad), Demyelination (narrow)
Write-up: Information has been received from a physician concerning a 60 year old female with stomach virus, allergy to Levaquin and drug hypersensitivity to codeine who on 10-OCT-2007 was vaccinated with a dose of Zostavax (Oka/Merck) (invalid lot# 0761409). There was no concomitant medication. In October 2007, the physician reported that "after receiving Zostavax (Oka/Merck) the patient had severe motor weakness of all extremities, but with no sensory loss, onset reported as 26-Oct-2007. The patient then saw a neurologist then admitted the patient immediately to the hospital. At the hospital the patient was diagnosed with Guillain-Barre Syndrome and was hospitalized for 6 days. Unspecified medical attention was sought. No product quality complaint. The physician reported that the patient is recovering and is going through physical therapy" Guillain-Barre Syndrome was considered serious due to hospitalization, immediately life-threatening and disabling. Upon internal review, Guillain-Barre Syndrome was also considered an Other Important Medical Event. Additional information has been requested. 11/19/07-records received for DOS 10/30-11/4/07-DC DX: Guillain-Barre syndrome. Benign essential hypertension, severe cerebromicrovascular disease, headache and low grade fever related to intravenous gamma globulin (presumed). Presented with several day history of pure ascending paralysis approximately two weeks after they vacationed in which she had a multitude of mosquito bites. Treated with IV gamma globulin.

VAERS ID:296434 (history)  Vaccinated:2007-10-19
Age:69.0  Onset:2007-10-20, Days after vaccination: 1
Gender:Female  Submitted:0000-00-00
Location:California  Entered:2007-11-12
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? Yes
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness: None
Preexisting Conditions: None PMH: occasional skipped heartbeats w/tachycardia, allergic rhinitis, goiter, asthma & chronic LBP. Allergy to sulfa.
Diagnostic Lab Data: CT head neg LABS: CT head showed small vessel ischemic changes. EKG WNL. Troponin slightly elevated 0.39. CXR WNL. MRI & MRA were WNL except for very small vessel ischemic changes.
CDC 'Split Type':
Vaccination
Manufacturer
Lot
Dose
Route
Site
VARZOS: ZOSTER (ZOSTAVAX)MERCK & CO. INC.0887U SCLA
Administered by: Private     Purchased by: Unknown
Symptoms: Amnesia, Cerebral ischaemia, Chest X-ray normal, Computerised tomogram normal, Electrocardiogram normal, Global amnesia, Nuclear magnetic resonance imaging, Nuclear magnetic resonance imaging brain abnormal, Troponin increased
SMQs:, Myocardial infarction (narrow), Ischaemic cerebrovascular conditions (narrow), Dementia (broad), Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow), Noninfectious encephalopathy/delirium (broad)
Write-up: Pt developed transient global amnesia-memory loss x 12 hrs after the vaccine. fully recovered. 11/27/07 Reviewed hospital medical records which reveal patient experienced acute onset of memory loss & recall for only events that happened 10/20. Admitted 10/20-10/21/2007. Memory returned approx 6-10 hours from initial onset & within 24 hours of admit was completely back to normal. FINAL DX: memory loss, transient, probably secondary to transient global amnesia. 12/21/07 Reviewed pcp medical records which consisted of H&P from hospitalization 10/20/07. No new information.

VAERS ID:297233 (history)  Vaccinated:2007-10-09
Age:  Onset:2007-10-09, Days after vaccination: 0
Gender:Male  Submitted:2007-11-16, Days after onset: 38
Location:Unknown  Entered:2007-11-19, Days after submission: 3
Life Threatening? Yes
Died? No
Permanent Disability? No
Recovered? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications: Unknown
Current Illness:
Preexisting Conditions: Unknown
Diagnostic Lab Data: Unknown
CDC 'Split Type': WAES0711USA02194
Vaccination
Manufacturer
Lot
Dose
Route
Site
VARZOS: ZOSTER (ZOSTAVAX)MERCK & CO. INC.  UNUN
Administered by: Other     Purchased by: Other
Symptoms: Encephalitis herpes, Incorrect dose administered
SMQs:
Write-up: Information has been received from a pharmacist concerning a male who on approximately 09-OCT-2007 (reported as "about a month ago") was vaccinated with a 0.5 ML dose of Zostavax (Oka/Merck). The pharmacist reported that the patient was hospitalized with herpetic encephalitis. The patient''s herpetic encephalitis persisted. The herpetic encephalitis was considered to be immediately life-threatening. There was no product quality complaint. In follow-up information received 09-NOV-2007, the pharmacist reported that she had limited information. She stated that a nurse came to the pharmacy and mentioned that they had a patient who was very sick and they were trying to figure out what was wrong with him. The nurse mentioned to the pharmacist that she reviewed the patient''s history and the patient had been vaccinated with Zostavax (Oka/Merck) about a month ago. The pharmacist did not have any additional information since she did not review the chart and did not know who the treating physician was. In follow-up information received on 13-NOV-2007, the pharmacist reported that the pharmacy department had no further information. Herpetic encephalitis was considered to be an other important medical event. No further information is available.

VAERS ID:297249 (history)  Vaccinated:2007-10-22
Age:77.0  Onset:2007-11-07, Days after vaccination: 16
Gender:Female  Submitted:2007-11-14, Days after onset: 7
Location:Michigan  Entered:2007-11-19, Days after submission: 5
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? Yes
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: hypertension; hypercholesterolemia; allergies to : amoxicillin, beta blockers, and ciproflaxacin 12/6/07-records received-PMH: UTIs, hypertension, osteoarthritis, gastric reflux, hyperlipidema.
Diagnostic Lab Data: Spinal CT scan (11/12/07): large pericardial fluid collection; Echocardiogram (11/13/07): moderate to large pericardial present, no tamponade 12/6/07-records received- 2 D echo and CT pulmonary angiogram revealed moderaly large pericardial effusion. CXR normal. Sed rate, erythropoietin and D-dimer elevated. Urinalysis contained WBC.stool leukocyte positive
CDC 'Split Type':
Vaccination
Manufacturer
Lot
Dose
Route
Site
FLU3: INFLUENZA (SEASONAL) (NO BRAND NAME)UNKNOWN MANUFACTURER  UNUN
VARZOS: ZOSTER (ZOSTAVAX)MERCK & CO. INC.  UNUN
Administered by: Unknown     Purchased by: Unknown
Symptoms: Angiogram, Asthenia, Atrial fibrillation, Blood erythropoietin increased, Chest X-ray normal, Computerised tomogram abnormal, Culture stool positive, Diarrhoea, Dyspnoea, Echocardiogram abnormal, Fatigue, Fibrin D dimer increased, Malaise, Pericardial effusion, Pyrexia, Red blood cell sedimentation rate increased, White blood cells urine positive
SMQs:, Anaphylactic reaction (broad), Haemorrhage laboratory terms (broad), Neuroleptic malignant syndrome (broad), Systemic lupus erythematosus (broad), Anticholinergic syndrome (broad), Supraventricular tachyarrhythmias (narrow), Pseudomembranous colitis (broad), Acute central respiratory depression (broad), Pulmonary hypertension (broad), Guillain-Barre syndrome (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Haemodynamic oedema, effusions and fluid overload (narrow), Cardiomyopathy (broad), Chronic kidney disease (broad), Noninfectious diarrhoea (narrow)
Write-up: Patient received influenza and Zostavax vaccines on 10/22. the next day she began to feel tired, weak, and generally not well. Over time she noticed shortness of breath with mild exertion. On admission she denied any fever, nausea, vomiting, diarrhea, abdominal pain, chest pain, headache, or neck stiffness. During hospitalization she did present with low grade fever along with previously described symptoms. A large pericardial effusion was detected upon further testing.12/06/07-records received for DOS 11/7-11/14/07- Developed diarrhea and stool leukocyte positive.Weak, low grade fever, malaise, dyspnea, atrial fibrillation. Impression: probably autoimmune phenomenon possible related to recent immunizations, Pericarditis. Per 60 day follow up: Atrial fibrillation developed during hospitalization related to acute pericarditis. Pt was discharged home 11/14/2007. Patient is still alive, had lab work 1/21/2008.

VAERS ID:297418 (history)  Vaccinated:0000-00-00
Age:70.0  Onset:0000-00-00
Gender:Male  Submitted:2007-11-19
Location:Massachusetts  Entered:2007-11-20, Days after submission: 1
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications: Unknown
Current Illness:
Preexisting Conditions: Unknown
Diagnostic Lab Data: Unknown
CDC 'Split Type': WAES0711USA02963
Vaccination
Manufacturer
Lot
Dose
Route
Site
FLU3: INFLUENZA (SEASONAL) (NO BRAND NAME)UNKNOWN MANUFACTURER  UNUN
VARZOS: ZOSTER (ZOSTAVAX)MERCK & CO. INC.  UNUN
Administered by: Unknown     Purchased by: Unknown
Symptoms: Dysuria, Syncope
SMQs:, Torsade de pointes/QT prolongation (broad), Arrhythmia related investigations, signs and symptoms (broad), Cardiomyopathy (broad), Hypotonic-hyporesponsive episode (broad)
Write-up: Information has been received from a physician concerning a male approximately in his "early 70''s" who at 08:00 (date unspecified) was vaccinated with a single dose of Zostavax (Oka/Merck). Concomitant vaccination administered on that same day at 08:00 included a dose of influenza virus vaccine (unspecified). Subsequently the patient experienced trouble urinating from about 12:00 until 04:00 and then fainted. The patient went to the emergency room and was subsequently admitted to the hospital for an overnight stay. The patient was able to urinate around 04:00 and was noted to be recovering. Medical treatment in the hospital was not specified. There was no product quality complaint. Additional information has been requested.

VAERS ID:297560 (history)  Vaccinated:2007-10-04
Age:68.0  Onset:2007-10-10, Days after vaccination: 6
Gender:Female  Submitted:0000-00-00
Location:Indiana  Entered:2007-11-23
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: PMH: HTN. Skin cancer.
Diagnostic Lab Data: LABS: brain MRI showed chronic small vessel ischemic changes. CBC revealed neutros 73.4% (H), lymphs 19.6% (L)
CDC 'Split Type':
Vaccination
Manufacturer
Lot
Dose
Route
Site
VARZOS: ZOSTER (ZOSTAVAX)MERCK & CO. INC.0886U0IMUN
Administered by: Private     Purchased by: Private
Symptoms: Abasia, Balance disorder, Blood pressure decreased, Blood test, Cerebral ischaemia, Computerised tomogram, Deafness neurosensory, Disorientation, Dizziness, Erythema, Hyperhidrosis, Lymphocyte count decreased, Nausea, Neutrophil percentage increased, Nuclear magnetic resonance imaging, Nuclear magnetic resonance imaging brain abnormal, Pain, Photophobia, Photosensitivity reaction, Pruritus, Rash, Tinnitus, Vertigo, Vestibular neuronitis, Vomiting
SMQs:, Anaphylactic reaction (narrow), Acute pancreatitis (broad), Haematopoietic leukopenia (narrow), Neuroleptic malignant syndrome (broad), Systemic lupus erythematosus (broad), Anticholinergic syndrome (narrow), Ischaemic cerebrovascular conditions (narrow), Dementia (broad), Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow), Dystonia (broad), Guillain-Barre syndrome (broad), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (narrow), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Glaucoma (broad), Corneal disorders (broad), Retinal disorders (broad), Hearing impairment (narrow), Vestibular disorders (narrow), Hypersensitivity (narrow)
Write-up: Received shot 10-4-07, 10-10-07 became dizzy nauseated, sweating, blood pressure dropped, ringing in the ears and sensitive to lights, 10-12-07 vomiting/ unable to walk, went to hospital. Cat Scan, MRI, IV''s, bloodtest. Went to ear specialist and had hearing checked 10-19-07 broke out in red, lumpy, painful rash that was itchy later. It lasted 2 weeks. 11-16-07 I''m still dizzy but slowly getting better. On October 4, 2007 I received the Zostavax vaccine at doctor''s office 10-10-07 I was shopping and I began to get real warm, sweat, and was very dizzy and nauseated. It lasted 6 hours. 10-11-07 the nausea started later in the day and lasted around 5 hours. I had a terrible ringing in my ears and lights were really hard on my eyes. My blood pressure kept dropping. The lights made more disoriented. 10-12-07 with-in 1/2 hour after getting up in the morning I was so dizzy and vomiting I could not function at all. I was taken to the emergency room. They took blood test, Cat Scan and put in IV''s. The doctor ordered an MRI and had me admitted to the hospital for over night. I left the hospital on 10-13-07 even though I was still having problems. I went for a check up with the doctor on 10-15-07 and she sent me to see an ear specialist for inner ear problems. He recommended I go for therapy. Before my appointment on 10-23-07 I had more side effects. On 10-19-07 I broke out in a red, itchy, lumpy rash. It feels like a bad sun burn. It extends from ears all the way to my stomach. It is the worst on my neck and chest. I''m slowly regaining my balance and being in well lit areas isn''t as bad on my eyes now. I was told I was probably contagious so I''m home bound until this clears up. This has been a very expensive side effect with all the testing, doctors, hospital and ambulance. 12/4/07 Reviewed ENT medical records which reveal patient seen 10/16/07 for continued vertigo which originally had been spinning & now was severe imbalance along w/continued tinnitus, photophobia & nausea/vomiting minimally controlled by meds. Audiogr

VAERS ID:297566 (history)  Vaccinated:2007-11-12
Age:64.0  Onset:2007-11-14, Days after vaccination: 2
Gender:Female  Submitted:2007-11-20, Days after onset: 6
Location:Pennsylvania  Entered:2007-11-23, Days after submission: 3
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Allergies - eggs; HTN; High cholesterol, Factor V Leidin; Osteoporosis; Anxiety PMH: plastic surgery 6 wks prior to admit. Factor 11 deficiency requiring FFP. HTN. Hyperlipidemia.
Diagnostic Lab Data: LABS: EKG sinus tachycardia. Troponin 0.19-0.21 was not considered diagnostic of myocardial injury. CBC, chemistry, LFT & TSH WNL. CXR WNL. Echocardiogram WNL. Stress test was WNL.
CDC 'Split Type':
Vaccination
Manufacturer
Lot
Dose
Route
Site
VARZOS: ZOSTER (ZOSTAVAX)MERCK & CO. INC.1080U0UNLA
Administered by: Private     Purchased by: Private
Symptoms: Asthenia, Blood thyroid stimulating hormone, Cardiac stress test normal, Chest X-ray normal, Dizziness, Dyspnoea exertional, Echocardiogram normal, Electrocardiogram abnormal, Fatigue, Full blood count normal, Injection site erythema, Injection site swelling, Injection site warmth, Laboratory test normal, Liver function test normal, Local reaction, Nausea, Palpitations, Sinus tachycardia, Tremor, Troponin increased
SMQs:, Acute pancreatitis (broad), Neuroleptic malignant syndrome (broad), Myocardial infarction (narrow), Anticholinergic syndrome (broad), Arrhythmia related investigations, signs and symptoms (broad), Supraventricular tachyarrhythmias (narrow), Parkinson-like events (broad), Pulmonary hypertension (broad), Guillain-Barre syndrome (broad), Noninfectious encephalopathy/delirium (broad), Extravasation events (injections, infusions and implants) (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Haemodynamic oedema, effusions and fluid overload (narrow), Cardiomyopathy (broad), Vestibular disorders (broad)
Write-up: 11/14/07 (-) Fever, (L) arm-site of injection-Red/warm/swollen- Rx Clobetasol Cream BID 11/15/07 TC prompt-states she feels weak/shakey + having heart palpitations-went to ER-Hospitalized overnight. 12/28/07 Reviewed hospital medical records which reveal patient experienced symptomatic palpitations with lightheadedness, fatigue, DOE & nausea since 11/12/07. Also had a local reaction to vax. Admitted 11/15-11/16/2007. Remained stable & d/c to home w/f/u troponin to be obtained as outpatient. FINAL DX: symptomatic sinus tachycardia.

VAERS ID:297887 (history)  Vaccinated:2007-08-14
Age:90.0  Onset:2007-08-20, Days after vaccination: 6
Gender:Female  Submitted:2007-11-26, Days after onset: 98
Location:Colorado  Entered:2007-11-27, Days after submission: 1
Life Threatening? No
Died? No
Permanent Disability? Yes
Recovered? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications: Unknown
Current Illness: Pain
Preexisting Conditions:
Diagnostic Lab Data: Unknown
CDC 'Split Type': WAES0711USA03655
Vaccination
Manufacturer
Lot
Dose
Route
Site
VARZOS: ZOSTER (ZOSTAVAX)MERCK & CO. INC.0744U UNUN
Administered by: Other     Purchased by: Other
Symptoms: Herpes zoster
SMQs:
Write-up: Information has been received from a physician concerning a 90 year old female who on 14-AUG-2007 was vaccinated with a dose of Zostavax (Oka/Merck) (lot number: 658082/0744U). On 20-AUG-2007 the patient developed shingles in the lower quadrant of her body. On 23-AUG-2007 the patient was hospitalized, but it was not specified how long the hospital stay was. The physician also reported that before receiving the vaccination, the patient had complained of non-descript pain in her lower quadrant of her body. No further adverse event information. There was no product quality complaint. The event was considered to be disabling by the reporter. Additional information has been requested.

VAERS ID:297888 (history)  Vaccinated:2007-03-22
Age:66.0  Onset:2007-06-14, Days after vaccination: 84
Gender:Female  Submitted:2007-11-26, Days after onset: 165
Location:Washington  Entered:2007-11-27, Days after submission: 1
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications: atenolol, ZETIA
Current Illness: Herpes virus infection; Drug hypersensitivity
Preexisting Conditions:
Diagnostic Lab Data: None
CDC 'Split Type': WAES0711USA03599
Vaccination
Manufacturer
Lot
Dose
Route
Site
VARZOS: ZOSTER (ZOSTAVAX)MERCK & CO. INC.  SCUN
Administered by: Other     Purchased by: Other
Symptoms: Cardiac disorder, Herpes zoster
SMQs:
Write-up: Information has been received from a 67 year old female with "little" herpes on her left hip and allergy to topical Lidocaine and morphine (makes her nauseous) who on 22-MAR-2007 was vaccinated SC with a 0.65 ml dose of Zostavax (Oka/Merck). Concomitant therapy included "DIGITEX", atenolol and ezetimibe (MSD). On approximately 14-JUN-2007 the patient developed shingles on her left hip. The patient believed that vaccination with Zostavax (Oka/Merck) turned her hip herpes into shingles. After patient developed shingles, she was hospitalized for "unrelated heart problems" and the hospital staff put a sign on her door saying that anyone who has not had chickenpox should not enter her room because her case was "so severe". It was stated that the patient was not hospitalized for shingles. At the time of the report the patient had not recovered. No diagnostic laboratory tests were undertaken. A product quality complaint was not involved. Additional information has been requested.

VAERS ID:297900 (history)  Vaccinated:2007-08-14
Age:60.0  Onset:2007-08-14, Days after vaccination: 0
Gender:Female  Submitted:2007-11-18, Days after onset: 96
Location:California  Entered:2007-11-27, Days after submission: 9
Life Threatening? Yes
Died? No
Permanent Disability? No
Recovered? Yes
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications: Lipitor, Evista, Multiple vitamins, low dose aspirin 1/day
Current Illness: None
Preexisting Conditions: 1993 ITP; Allergies to dust, pollen, some insects. PMH: Persistant vertigo. Allergies to IVP dye, Talwin, Demerol.
Diagnostic Lab Data: See #7 Blood work results Platelet count less than 39,000 by 8-17-07. Note: Platelets were in normal range prior. Labs and Diagnostics: CBC with platelet count 69,000.
CDC 'Split Type':
Vaccination
Manufacturer
Lot
Dose
Route
Site
VARZOS: ZOSTER (ZOSTAVAX)MERCK & CO. INC.0744U0SCLA
Administered by: Private     Purchased by: Other
Symptoms: Cellulitis, Full blood count, Immunisation reaction, Injection site erythema, Injection site induration, Injection site pruritus, Injection site swelling, Injection site warmth, Platelet count decreased
SMQs:, Haematopoietic thrombocytopenia (narrow), Systemic lupus erythematosus (broad), Extravasation events (injections, infusions and implants) (broad), Haemodynamic oedema, effusions and fluid overload (narrow)
Write-up: 8-14-07 Injection site became red, very itchy hot. 8-15-07 Increased redness, swelling at site, itchy, Nurse contacted. 8-16-07 Redness/swelling increased, began travelling down arm towards elbow. Doctor visit - concern about infection - antibiotic/antihistamine prescribed. Lab work taken (blood). Cellulitis, possible allergic reaction. 8-17-07 Lab results received. Extremely low platelet count; referral to hematologist, who followed my progress and continued until counts back in normal range. 11/28/2007 MR received for OVs beginning 8/13/07 to 8/16/07. Seen 8/16/07 for Reaction to Shingles vaccine. L arm with large red indurated area. Txd with abx and antihistamines.

Result pages: prev   3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21   next

New Search

Link To This Search Result:
http://www.medalerts.org/vaersdb/findfield.php?EVENTS=ON&PAGENO=12&VAX[]=VARZOS&SERIOUS=ON


Copyright © 2014 National Vaccine Information Center. All rights reserved.
407-H Church Street, Vienna, Virginia 22180